Results 101 to 110 of about 18,957 (200)

Effectiveness and tolerability of transdermal rivastigmine in the treatment of Alzheimer’s disease in daily practice

Neuropsychiatric Disease and Treatment, 2012
Johannes Seibert1, Ferenc Tracik2,3, Konstantin Articus2, Stefan Spittler41Outpatient Clinic, Heidelberg, Germany; 2Novartis Pharma, Nürnberg, Germany; 3Department of Neurology, Heinrich-Heine University, Düsseldorf, Germany; 4Alexianer
Seibert J, Tracik F, Articus K, Spittler S   +3 more
doaj  

The evaluation of cognitive function in the dementias: methodological and regulatory considerations [PDF]

, 2018
This is the final version of the article. Available from the publisher via the NCBI link in this record.Impairment of cognitive function is the central feature of dementia. Although, clinically, the cognitive deficit most often manifests itself as memory
Harrison, JE, Wesnes, KA
core  

Experimental pharmacological research regarding some new quinazolin-4-ones derivatives [PDF]

, 2019
A series of new compounds with quinazolin-4-one structure, synthesized by the Pharmaceutical Chemistry Department of the Faculty of Pharmacy of the University of Medicine and Pharmacy “Carol Davila” Bucharest, was studied.
Bratu, Mihaela, Chiriță, Cornel, Chiriță, Ileana C, Limban, Carmen, Marineci, Cristina D, Negreș, Simona, Nuță, Diana C, Zbârcea, Cristina E, Ștefănescu, Emil   +8 more
core   +1 more source

Adverse drug events affecting medication persistence with rivastigmine patch application

Patient Preference and Adherence, 2018
Takashi Osada,1 Norio Watanabe,1 Naomitsu Asano,2 Yuzo Adachi,2 Keiko Yamamura1 1Clinical Pharmacy, School of Pharmacy, Aichi Gakuin University, Nagoya, Aichi, Japan; 2Sasayuri Pharmacy, Toki, Gifu, Japan Purpose: The rivastigmine transdermal patch ...
Osada T, Watanabe N, Asano N, Adachi Y, Yamamura K   +4 more
doaj  

Prior Authorization as a Potential Support of Patient-Centered Care. [PDF]

, 2018
We discuss the role of prior authorization (PA) in supporting patient-centered care (PCC) by directing health system resources and thus the ability to better meet the needs of individual patients. We begin with an account of PCC as a standard that should
Berger, Zackary, Rand, Leah
core  

Movement disorders associated with acetylcholinesterase inhibitors in Alzheimer’s dementia: A systematic review

Brain Circulation
BACKGROUND: Acetylcholinesterase inhibitors (AChEIs) are widely used in Alzheimer’s disease (AD). This study aims to systematically review the literature about movement disorders (MDs) associated with AChEIs for AD, which include donepezil, galantamine ...
Jamir Pitton Rissardo, Ana Letícia Fornari Caprara   +1 more
doaj   +1 more source

Determination of Alzheimer’s Drugs in a Human Urine Sample by Different Chemometric Methods

International Journal of Analytical Chemistry
In this study, spectrophotometric determination of donepezil and rivastigmine in healthy human urine samples was carried out by the statistical method.
Güzide Pekcan
doaj   +1 more source

Cognitive and behavioural predictors of survival in Alzheimer disease:results from a sample of treated patients in a tertiary-referral memory clinic [PDF]

, 2012
Agüero-Torres, Andersen, Brandt, Brookmeyer, Buchner, Cox, Cummings, Doody, Ferri, Folstein, Gambassi, General Register Office for Scotland, Helmer, Hicks, Hötte, Inouye, ISD Scotland, Kaplan, Knopman, Landi, Larson, Lawton, Lezak, Luchsinger, Martyn, McGurn, McKhann, Mental Welfare Commission for Scotland, Mielke, Miller, Morgan, Musicco, Nelson, Newcomer, Rait, Reisberg, Richards, Robbins, Scarmeas, Scarmeas, Schneider, Sinforiani, Solfrizzi, SPSS Inc, Starr, Starr, Starr, Starr, Stern, Stern, Stern, Stern, Thomas, Tsai, Tun, Van Dijk, Wang, Whalley, Whitmer, Wolfson   +59 more
core   +1 more source

Skin Lesions as Signs of Neuroenhancement in Sport

Brain Sciences
Background: Neuroenhancement in sports, through pharmacological and non-pharmacological methods, is a complex and highly debated topic with no definitive regulatory framework established by the World Anti-Doping Agency (WADA).
Sorana-Cristiana Popescu, Roman Popescu, Vlad Voiculescu, Carolina Negrei   +3 more
doaj   +1 more source

Antimuscarinic Toxicity Safely Managed with High-Dose Transdermal Rivastigmine: A Case Report. [PDF]

Clin Pract Cases Emerg Med
Watson CJ, Burrill EM, Jaffee WS.
europepmc   +1 more source